11-55665704-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004704.2(OR4C6):āc.538T>Cā(p.Phe180Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000266 in 1,613,962 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001004704.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR4C6 | NM_001004704.2 | c.538T>C | p.Phe180Leu | missense_variant | 2/2 | ENST00000314259.5 | NP_001004704.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR4C6 | ENST00000314259.5 | c.538T>C | p.Phe180Leu | missense_variant | 2/2 | 6 | NM_001004704.2 | ENSP00000324769.3 | ||
OR4C6 | ENST00000690330.1 | c.538T>C | p.Phe180Leu | missense_variant | 1/1 | ENSP00000508428.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152012Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000123 AC: 31AN: 251226Hom.: 0 AF XY: 0.000133 AC XY: 18AN XY: 135764
GnomAD4 exome AF: 0.0000260 AC: 38AN: 1461832Hom.: 0 Cov.: 32 AF XY: 0.0000330 AC XY: 24AN XY: 727224
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152130Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.538T>C (p.F180L) alteration is located in exon 1 (coding exon 1) of the OR4C6 gene. This alteration results from a T to C substitution at nucleotide position 538, causing the phenylalanine (F) at amino acid position 180 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at